{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:27:50Z","timestamp":1783024070796,"version":"3.54.6"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    Succinate dehydrogenase-deficient renal cell carcinoma is a rare and recently recognized distinct subtype of renal cell carcinoma. Usefulness of FDG PET\/CT in the management of this tumor is rarely reported. We describe FDG PET\/CT findings in a case of succinate dehydrogenase-deficient renal cell carcinoma with lung metastases. The lung metastases &lt;2\u00a0cm showed high FDG uptake with SUV\n                    <jats:sub>max<\/jats:sub>\n                    of 19.1, which may be due to extreme Warburg effect resulting from succinate dehydrogenase mutation. This case indicates FDG PET\/CT may be useful for detecting and staging of this novel tumor, which needs to be investigated in future studies.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006394","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:07:28Z","timestamp":1777907248000},"page":"677-679","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Intense FDG Uptake of Lung Metastases From Succinate Dehydrogenase-deficient Renal Cell Carcinoma"],"prefix":"10.1097","volume":"51","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital, Jiaxing University, Jiaxing, Zhejiang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisheng","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shanghai Fourth People\u2019s Hospital Affiliated to Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.5858\/arpa.2017-0199-RS","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: a short review","volume":"142","author":"Wang","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41379-021-00998-1","article-title":"Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients","volume":"35","author":"Fuchs","year":"2022","journal-title":"Mod Pathol"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"e230063","DOI":"10.1148\/rycan.230063","article-title":"The prevalence and radiologic features of renal cancers associated with FLCN, BAP1, SDH, and MET germline mutations","volume":"6","author":"Charbel","year":"2024","journal-title":"Radiol Imaging Cancer"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"e7799","DOI":"10.1002\/ccr3.7799","article-title":"Imaging findings of succinate dehydrogenase-deficient renal cell carcinoma","volume":"11","author":"Liu","year":"2023","journal-title":"Clin Case Rep"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1159\/000531059","article-title":"Succinate dehydrogenase defects giant renal cell carcinoma","volume":"107","author":"Sun","year":"2023","journal-title":"Urol Int"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1308\/rcsann.2020.0196","article-title":"SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling","volume":"103","author":"Wilczek","year":"2021","journal-title":"Ann R Coll Surg Engl"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/cren.2017.0140","article-title":"Hand-assisted laparoscopic partial nephrectomy for large renal carcinoma with succinate dehydrogenase deficiency","volume":"4","author":"Bersang","year":"2018","journal-title":"J Endourol Case Rep"},{"key":"R10-20260702","first-page":"102412","article-title":"Adolescent male with bilateral succinate dehydrogenase-deficient renal cell carcinoma in a horseshoe kidney managed successfully with staged bilateral robotic-assisted partial nephrectomies: a case report","volume":"49","author":"Pulford","year":"2023","journal-title":"Urol Case Rep"},{"key":"R11-20260702","first-page":"PO.16.00007","article-title":"Persistent severe hyperlactatemia and metabolic derangement in lethal SDHB-mutated metastatic kidney cancer: clinical challenges and examples of extreme Warburg effect","volume":"1","author":"Lee","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/iju5.12520","article-title":"Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma","volume":"5","author":"Yamaguchi","year":"2022","journal-title":"IJU Case Rep"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:10:27Z","timestamp":1783023027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006394","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"2026-01-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}